Max Robotics — Global Service Robot Directory + US Certification

About

Mohamed M. Abdel‐Daim is a pioneering researcher at the intersection of regenerative medicine and artificial intelligence in healthcare. His seminal 2022 work, "Future regenerative medicine developments and their therapeutic applications," with 80 citations, critically examines the limitations of conventional pharmacology in treating irreversible tissue damage—such as myocardial infarction, organ failure, and amputated limbs—and charts a path forward for stem cell therapies and tissue engineering. This foundational contribution has shaped discussions on overcoming current therapeutic ceilings. More recently, his 2025 comprehensive review, "Transforming healthcare: the impact of artificial intelligence on diagnostics, pharmaceuticals, and ethical considerations," addresses the pressing challenge of interpretability in AI-driven clinical tools, where misdiagnosis can have life-threatening consequences. By synthesizing advances in machine learning for drug discovery and diagnostic imaging, while foregrounding ethical frameworks, Abdel‐Daim bridges technical innovation with patient safety. His work is notable for its translational focus, urging the healthcare sector to responsibly integrate AI without compromising trust. With a growing citation footprint, Abdel‐Daim stands as a key voice guiding the next generation of researchers toward safer, more effective regenerative and AI-enhanced therapies.